Ajay Bapna
Jaipur, RJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world treatment patterns and outcomes in Indian patients with HR+/HER2- advanced breast cancer treated with palbociclib.
Journal: Journal of cancer research and therapeutics
Published: July 23, 2025
Real-World Evidence of the Impact of CanAssist Breast on Physician's Decision About the Use of Adjuvant Chemotherapy in Early Breast Cancer.
Journal: Cureus
Published: December 12, 2024
The Rs 100 "R+Cu" (resveratrol and copper) anti-cancer magic tablet controversy: Results of online survey among oncologists.
Journal: Indian journal of cancer
Published: March 06, 2024
Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method.
Journal: BMC cancer
Published: May 18, 2022
Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India.
Journal: South Asian journal of cancer
Published: January 05, 2022
South Asian Declaration-Consensus Guidelines for COVID-19 Vaccination in Cancer Patients.
Journal: South Asian journal of cancer
Published: August 25, 2021
Indian Expert Opinion on Cancer Care during COVID-19 Pandemic.
Journal: South Asian journal of cancer
Published: August 25, 2021
Myelodysplastic syndrome/myeloproliferative neoplasm - ring sideroblast with myelofibrosis - A diagnostic dilemma/? A distinct entity.
Journal: Indian journal of pathology & microbiology
Published: April 14, 2021
Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology.
Journal: JCO global oncology
Published: July 07, 2020
Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: June 27, 2018
Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 05, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026